CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating Activities
Net income (loss)	$ (14,872,000)	$ (49,348,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	886,000	903,000
Stock-based compensation	3,307,000	3,207,000
Amortization of right-of-use asset	98,000	0
Noncash lease expense	0	273,000
Noncash interest expense (including related party amounts of $1,330 and $160 for the nine months ended September 30, 2024 and 2023, respectively)	1,787,000	300,000
Loss on issuance of financial instruments (including related party amounts of $639 and zero for the nine months ended September 30, 2024 and 2023, respectively)	17,876,000	24,475,000
Loss on amendments to financial instruments, net	3,940,000	0
Change in fair value of financial instruments (including related party amounts of $494 and $12 for the nine months ended September 30, 2024 and 2023, respectively)	(31,004,000)	1,043,000
Loss on sale of property and equipment, net	9,000	0
Transaction costs expensed	0	3,329,000
Changes in operating assets and liabilities:
Accounts receivable	0	29,000
Prepaid expenses and other current assets	925,000	(1,037,000)
Accounts payable and accrued expenses	2,991,000	2,100,000
Other current liabilities	206,000	0
Operating lease liability	(77,000)	(283,000)
Net cash used in operating activities	(13,928,000)	(15,009,000)
Investing activities
Sales of property and equipment	35,000	0
Purchases of capitalized software	(32,000)	(30,000)
Net cash provided by (used in) investing activities	3,000	(30,000)
Financing activities
Proceeds from exercise of common stock options	0	12,000
Proceeds from amendment to the FPA agreements	2,112,000	0
Proceeds received from sale of FPA Shares	873,000	0
Proceeds from issuance of bridge notes	200,000	0
Proceeds from issuance of PIPE warrants	0	10,210,000
Proceeds from exercise of the PIPE warrants	250,000	0
Proceeds from related party loans	0	5,300,000
Proceeds from draws on revolving line of credit	0	4,931,000
Proceeds from issuance of common stock	99,000	1,667,000
Payment in connection with letter agreements	(116,000)	0
Payment of transaction costs	0	(13,055,000)
Payment of debt issuance and modification costs on revolving line of credit	0	(72,000)
Less: Payment of Graf deferred underwriter fees	0	(1,250,000)
Payment of bridge notes	(215,000)	0
Proceeds from repayments of receivable from shareholder	500,000	0
Net cash provided by financing activities	13,886,000	23,958,000
Net increase (decrease) in cash, cash equivalents, and restricted cash	(39,000)	8,919,000
Cash, cash equivalents, and restricted cash at the beginning of period	276,000	117,000
Cash, cash equivalents, and restricted cash at the end of period	237,000	9,036,000
Cash and cash equivalents	8,000	8,786,000
Restricted cash	229,000	250,000
Total cash, cash equivalents, and restricted cash	237,000	9,036,000
Supplemental cash flow information
Cash paid for interest expense	401,000	0
Supplemental disclosure of noncash investing and financing activities
Conversion of liability classified warrants to equity pursuant to sequencing policy	297,000	0
Right-of-use asset obtained in exchange for new operating lease liability	513,000	0
Exercise of tranche right derivative	572,000	0
Initial issuance of subscription receivable	625,000	0
Capitalized software costs included in accounts payable and accrued expenses	16,000	15,000
Conversion of convertible promissory notes	101,000	0
Issuance of subscription receivable	0	32,915,000
Unpaid transaction costs included in accounts payable and accrued expenses	0	7,338,000
Assumption of derivative warrant liabilities	$ 0	$ 2,045,000
Basic (in shares)	25,112,714	13,342,568
Convertible Promissory Notes
Financing activities
Proceeds from convertible debt	$ 11,608,000	$ 6,215,000
Payment of financing fees related to convertible promissory notes	(328,000)	0
Repayments of convertible debt	(953,000)	0
Supplemental disclosure of noncash investing and financing activities
Conversion of liability classified stock to equity	0	18,913,000
Convertible Promissory Notes Due to Related Parties and Warrants
Financing activities
Proceeds from convertible debt	0	10,000,000
Convertible Bridge Loans
Financing activities
Proceeds from convertible debt	700,000	0
Repayments of convertible debt	(844,000)	0
Stock to Equity
Supplemental disclosure of noncash investing and financing activities
Conversion of liability classified stock to equity	$ 4,024,000	$ 0